Procter & Gamble (NYSE:PG) Research Coverage Started at BNP Paribas

BNP Paribas started coverage on shares of Procter & Gamble (NYSE:PG) in a research report sent to investors on Monday morning, Marketbeat.com reports. The firm issued an outperform rating and a $187.00 price objective on the stock.

Several other equities analysts have also weighed in on PG. Argus boosted their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a buy rating in a report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Procter & Gamble from $172.00 to $171.00 and set a buy rating for the company in a research note on Monday, April 22nd. Barclays upped their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an overweight rating in a research report on Tuesday, April 23rd. StockNews.com downgraded shares of Procter & Gamble from a buy rating to a hold rating in a report on Monday, June 17th. Finally, Truist Financial upgraded shares of Procter & Gamble from a hold rating to a buy rating and increased their price target for the company from $160.00 to $175.00 in a report on Monday, March 11th. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of $170.72.

Procter & Gamble Stock Up 0.3 %

Shares of NYSE PG opened at $167.37 on Monday. The firm has a market cap of $395.02 billion, a price-to-earnings ratio of 27.36, a price-to-earnings-growth ratio of 3.39 and a beta of 0.42. Procter & Gamble has a 52-week low of $141.45 and a 52-week high of $169.41. The company’s 50-day simple moving average is $165.07 and its 200-day simple moving average is $158.47. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. Procter & Gamble’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the previous year, the business posted $1.37 earnings per share. Equities analysts predict that Procter & Gamble will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a $1.0065 dividend. The ex-dividend date was Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a dividend yield of 2.41%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.

Insider Activity at Procter & Gamble

In related news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now owns 19,042 shares in the company, valued at $3,179,061.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the transaction, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at approximately $3,179,061.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now directly owns 4,004 shares in the company, valued at $634,634. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 154,544 shares of company stock worth $25,413,051. Company insiders own 0.17% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP grew its position in shares of Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after buying an additional 3,047,557 shares in the last quarter. Norges Bank acquired a new stake in shares of Procter & Gamble during the fourth quarter worth approximately $3,956,117,000. Charles Schwab Investment Management Inc. grew its position in shares of Procter & Gamble by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock worth $2,336,552,000 after buying an additional 206,165 shares in the last quarter. Royal Bank of Canada boosted its holdings in Procter & Gamble by 3.2% in the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock worth $1,629,299,000 after purchasing an additional 346,925 shares during the period. Finally, Fisher Asset Management LLC boosted its holdings in Procter & Gamble by 5.6% in the fourth quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock worth $1,547,021,000 after purchasing an additional 559,358 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.